This case is a class action securities litigation brought by institutional investors on behalf of purchasers of Royal Dutch/Shell securities, alleging that the company and its executives and auditors disseminated materially false statements overstating proved oil and gas reserves, reserves replacement ratios, and future cash flows in SEC filings, annual reports, and other public statements from 1999 to 2004, in violation of Sections 10(b), 14(a), and 20(a) of the Securities Exchange Act. The defendants moved to dismiss under Rules 12(b)(1) for lack of subject matter jurisdiction, 12(b)(2) for lack of personal jurisdiction over individual defendant Watts, and 12(b)(6) for failure to state a claim, with additional challenges based on statute of limitations, res judicata, and international comity. The court addressed whether U.S.-based activities such as audits at Shell Deepwater Services in Houston and investor relations provided a sufficient basis for jurisdiction under the Exchange Act and evaluated the adequacy of scienter and reliance allegations tied to the reserves reporting.
This case involved plaintiff William Colarusso's claim against the Estate of Eugene T. Day, Jr. under ERISA Section 502(c)(1) for failing to provide requested information about an employee benefit plan in which Colarusso participated while employed at Transcapital Fiscal Systems, Inc. The court determined that the Top Hat Value Added Plan was covered by ERISA, that Day served as both plan administrator and fiduciary, and that he violated ERISA by not furnishing plan documents or termination notices in response to Colarusso's requests. After a bench trial, the court imposed civil penalties on Day's estate at a rate of $50 per day for 928 days, totaling $46,400 plus post-judgment interest, but limited the penalty period to end on the date of Day's death in February 1997 because the provision's purpose is punitive. The ruling followed from findings that the plan imposed fiduciary duties, Day qualified as a fiduciary under ERISA definitions, and the statutory penalty applied to the information disclosure violations.
This case involved a dispute over the validity of Schering's U.S. Patent No. 4,659,716 ('716 patent), which claims the compound DCL, a metabolite of the antihistamine loratadine covered by Schering's earlier '233 patent. Generic drug manufacturers challenged the '716 patent's validity, arguing it was anticipated by the prior '233 patent. The court granted summary judgment to the defendants, holding Claims 1 and 3 of the '716 patent invalid under 35 U.S.C. § 102(b) due to inherent anticipation. The reasoning was that administering loratadine to humans, as disclosed in the prior art patent, necessarily produces DCL in the body, making the metabolite inherently present in the prior disclosure regardless of whether it was explicitly identified.
This case concerns newspaper publishers suing Attorney General John Ashcroft and Chief Immigration Judge Michael Creppy over a post-September 11, 2001 memorandum that closed certain "special interest" deportation hearings to the public and press, restricted docket information, and applied without individualized determinations. Plaintiffs sought a preliminary injunction asserting a First Amendment right of access to these proceedings under federal regulations, while defendants moved to dismiss for lack of jurisdiction and failure to state a claim. The court denied the motion to dismiss, confirming federal question jurisdiction under 28 U.S.C. § 1331, and analyzed the merits by examining precedents on public access to trials, the nature of immigration hearings, and limits on blanket closures.
The case concerns enforcement of a 1987 Consent Decree resolving a class action (Bronze Shields v. City of Newark) alleging racial discrimination in the City's police hiring practices. Class member Lester J. Elliott sought appointment to the police force under the decree's preferential hiring list for victims of past discrimination, but the City objected on the ground that he was not a Newark resident at the time of his reapplication. The court ruled that the City must appoint Elliott, holding that New Jersey statutes (N.J.S.A. 40A:14-122.1 and 40A:14-123.1a) bar municipalities from treating residency as a qualification or requirement for initial police appointments and permit only a voluntary priority system among qualified applicants. The core reasoning distinguishes between prohibited residency requirements (which would disqualify non-residents) and permissible preferences (which do not override the decree's priority scheme for class members), while noting the City's prior acceptance of the decree's terms.
This case involved a physician with a history of substance abuse who sought an unrestricted medical license from the New Jersey Board of Medical Examiners, along with the Medical Society of New Jersey, challenging a policy by the Director of Consumer Affairs that required public disclosure and proceedings for substance abuse-related cases instead of private letters of agreement used for other disciplinary matters. The plaintiffs alleged violations of Title II of the Americans with Disabilities Act and the Equal Protection Clause, claiming discrimination against physicians with disabilities. The court granted the defendants' motion to dismiss, ruling that the Medical Society lacked associational standing and that the individual physician's claims were not ripe, resulting in dismissal for lack of subject matter jurisdiction under Rule 12(b)(1). Most claims were dismissed with prejudice, while the Society's ADA claim was dismissed without prejudice. The decision rested on justiciability doctrines rather than the merits of the discrimination allegations.
